Thanks Rawman for the link to the Supplement Disclosure Document. Facts and documents are always welcome to the discussion.
I agree that there is no imminent distribution. That have stated that they have secured at least $1M for manufacturing equipment and the new test kits will be manufactured by their current partners who also have motivation to make it happen, being at one of the centers of Covid-19 in South Korea.
I am hopeful, but I have no track record with the company. The recent PRs altogether, point to a "potential" promising outcome. Companies like BMRA, trading above $8 talk about ramping up to produce 1M test kits a month. Well, that means 5 months from now that's only 5M kits. Abbott's weekly to monthly figures weren't extraordinary and if a vaccine is a year away and hundreds of million may need to be tested in a somewhat ongoing manner for the world to open back up to work, that means the market for test kits will not have been at all saturated by August.
So if you were going to a drive thru and at one drive through, the wait was 15 min for every "order" and another drive thru was serving up orders every 15 seconds, it seems likely the 15 second drive through would capture as much market as they could produce.
Berman has raised his initial target from 420M to 525M. What that is based on I don't know, but everyone should realize those numbers are based on a home test kit that is not yet on the screen for approval.
Still, given the price of the stock, the market not going away and the potential for sales of any rapid kits in the millions, I'm optimistic as to where this stock might be in Sept vs today.
In one PR, they did state that the test kit was proven in South Korea for both H1N1 and the coronavirus. I don't know how true that is nor how it came about, but it was in one of the PRs. So it seems that they are extremely confident their kits will work or they wouldn't be borrowing the money and ordering the materials I wouldn't think.
Thanks again for the link. I'll read that document.
